Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsENTERALStandard

DUOPA

CARBIDOPA; LEVODOPA

Standard Dose
4.63MG/ML;20MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview DUOPA is listed in Drugs@FDA under application 203952 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient CARBIDOPA; LEVODOPA Form and strength SUSPENSION;ENTERAL - 4.63MG/ML;20MG/ML Sponsor ABBVIE Submission history Latest submission status date: 2026-03-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview DUOPA is listed in Drugs@FDA under application 203952 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CARBIDOPA; LEVODOPA Form and strength SUSPENSION;ENTERAL - 4.63MG/ML;20MG/ML Sponsor ABBVIE Submission history Latest submission status date: 2026-03-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.